Oroxin A
CAS No. 57396-78-8
Oroxin A( —— )
Catalog No. M18837 CAS No. 57396-78-8
Oroxin A has antitussive and expectorant effects.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 83 | In Stock |
|
| 5MG | 75 | In Stock |
|
| 10MG | 130 | In Stock |
|
| 25MG | 221 | In Stock |
|
| 50MG | 341 | In Stock |
|
| 100MG | 496 | In Stock |
|
| 200MG | 705 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameOroxin A
-
NoteResearch use only, not for human use.
-
Brief DescriptionOroxin A has antitussive and expectorant effects.
-
DescriptionOroxin A has antitussive and expectorant effects.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number57396-78-8
-
Formula Weight432.38
-
Molecular FormulaC21H20O10
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 125 mg/mL (289.10 mM)
-
SMILESO=C3C=C(Oc2cc(O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O)c(O)c(O)c23)c4ccccc4
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Elezanumab
Elezanumab(ABT-555) is a potent human anti-RGMa monoclonal antibody.Elezanumab exerts its inhibitory effect on RGMa-mediated BMP signaling through the SMAD1/5/8 pathway, with an IC50 of approximately 97 pM.
-
HBV core14, (HBA31)
HBV core14, (HBA31)
-
Laminaran
Laminaran is a β-1,3-glucan isolated from brown algae, often serving as a typical ligand for Dectin-1.
Cart
sales@molnova.com